跳至主要内容
临床试验/JPRN-UMIN000009107
JPRN-UMIN000009107招募中未知

A clinical study on safety and efficacy of combined intraarterial cisplatin and 5-fluorouracil with systemic pegylated interferon alfa-2b for advanced hepatocellular carcinoma - A combination therapy of CDDP / 5-FU / PEG-IFN alfa-2b for advanced hepatocellular carcinoma. : study of safety and efficacy

Iwate Medical University0 个研究点目标入组 60 人开始时间: 2012年10月13日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Pregnant or breast-feeding patients. 2.Patients with hypersensitivity to Pt-drug and IFN 3.Severe complication 4.Patients with interstitial pneumonia or a history 5.Patients with central nervous system disorders , the depression or a history 6.Inappropriate patients for this study judged by physicians.

研究者

相似试验

A clinical study on safety and efficacy of combined... | 临床试验